Information Provided By: 
Fly News Breaks for May 24, 2019
SPLK
May 24, 2019 | 08:41 EDT
Guggenheim analyst Imtiaz Koujalgi said Splunk reported a mixed quarter, with headline metrics above consensus but billings and cash flow weighed down by a ratable mix shift, increasing contract duration and shrinking invoicing duration. Noting that the company expects the invoicing duration to be a headwind for the rest of the year and guided down its operating cash flow, Koujalgi lowered Splunk's price target to $115 from $125 and keeps a Neutral rating on the stock.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
